Featured Research

from universities, journals, and other organizations

Hypertension Drug Dramatically Reduces Proteinuria In Kidney Disease Patients

Date:
February 22, 2009
Source:
American Society of Nephrology
Summary:
Taking a much higher than recommended dose of the hypertension drug candesartan cilexetil effectively lowered the amount of protein excreted in the urine of patients with kidney disease, according to a new study. By reducing such proteinuria, the drug could potentially prevent the development of serious complications such as end-stage kidney disease and therefore save many patients' lives.

Taking a much higher than recommended dose of the hypertension drug candesartan cilexetil effectively lowered the amount of protein excreted in the urine of patients with kidney disease, according to a new study. By reducing such proteinuria, the drug could potentially prevent the development of serious complications such as end-stage kidney disease and therefore save many patients' lives.

Many research efforts are focused on finding ways to lower urinary protein excretion in patients with kidney disease because doing so may postpone kidney failure and prevent the development of cardiovascular disease. Investigators in Canada recently reported the results of a multicenter trial that evaluated whether high doses of the hypertension drug candesartan cilexetil could reduce proteinuria better than the maximum approved dose. This drug is an angiotensin receptor blocker, an agent that reduces blood pressure by blocking several of the effects of the hormone angiotensin II, including tightening and thickening of the arteries, secretion of the hormone aldosterone, and reabsorption of sodium by the kidney. Because angiotensin receptor blockers also have effects on fibrosis and inflammation in the kidney, these drugs are also used to prevent or slow the progression of kidney failure.

The trial, led by Ellen Burgess, MD, of the University of Calgary in Alberta, Canada, enrolled 269 patients who had persistent proteinuria despite treatment with the highest approved dose of candesartan (16 mg daily at the time the study was initiated). Patients were randomized to receive 16, 64, or 128 mg daily of candesartan for 30 weeks.

The investigators found that patients taking 128 mg of candesartan experienced more than a 33% reduction in proteinuria compared with those receiving 16 mg candesartan by the end of the study. This reduction was in addition to the reduction in proteinuria that the patients would have had when they first started taking candesartan at 16 mg daily.

"We were surprised to see such a dramatic effect since, in the end, several other studies using higher-than-approved doses of angiotensin receptor blockers were not able to show benefit," said Dr. Burgess.

Additional research is needed to determine the optimal dose of candesartan for lowering proteinuria. However this study proves that "proteinuria that persists despite treatment with the maximum recommended dose of candesartan can be reduced by increasing the dose of candesartan further," the authors wrote. While high dose therapy with candesartan was well-tolerated, 11 patients dropped out of the study due to high blood potassium levels. Therefore, the researchers recommend that potassium levels be monitored during treatment with this drug.

The authors acknowledge the support of AstraZeneca Canada for their support and funding of this study. AstraZeneca Canada also assisted the Planning Committee with statistical expertise in the design and analysis of the study.


Story Source:

The above story is based on materials provided by American Society of Nephrology. Note: Materials may be edited for content and length.


Journal Reference:

  1. Supramaximal Dose of Candesartan in Proteinuric Renal Disease. Journal of the American Society Nephrology, Online February 11, 2009; In print April 2009 DOI: 10.1681/ASN.2008040416

Cite This Page:

American Society of Nephrology. "Hypertension Drug Dramatically Reduces Proteinuria In Kidney Disease Patients." ScienceDaily. ScienceDaily, 22 February 2009. <www.sciencedaily.com/releases/2009/02/090211193803.htm>.
American Society of Nephrology. (2009, February 22). Hypertension Drug Dramatically Reduces Proteinuria In Kidney Disease Patients. ScienceDaily. Retrieved September 22, 2014 from www.sciencedaily.com/releases/2009/02/090211193803.htm
American Society of Nephrology. "Hypertension Drug Dramatically Reduces Proteinuria In Kidney Disease Patients." ScienceDaily. www.sciencedaily.com/releases/2009/02/090211193803.htm (accessed September 22, 2014).

Share This



More Health & Medicine News

Monday, September 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Sierra Leone in Lockdown to Control Ebola

Sierra Leone in Lockdown to Control Ebola

AP (Sep. 21, 2014) Sierra Leone residents remained in lockdown on Saturday as part of a massive effort to confine millions of people to their homes in a bid to stem the biggest Ebola outbreak in history. (Sept. 20) Video provided by AP
Powered by NewsLook.com
Sierra Leone's Nationwide Ebola Curfew Underway

Sierra Leone's Nationwide Ebola Curfew Underway

Newsy (Sep. 20, 2014) Sierra Leone is locked down as aid workers and volunteers look for new cases of Ebola. Video provided by Newsy
Powered by NewsLook.com
Changes Found In Brain After One Dose Of Antidepressants

Changes Found In Brain After One Dose Of Antidepressants

Newsy (Sep. 19, 2014) A study suggest antidepressants can kick in much sooner than previously thought. Video provided by Newsy
Powered by NewsLook.com
Could Grief Affect The Immune Systems Of Senior Citizens?

Could Grief Affect The Immune Systems Of Senior Citizens?

Newsy (Sep. 19, 2014) The study found elderly people are much more likely to become susceptible to infection than younger adults going though a similar situation. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins